Tuesday, October 21, 2025
INBV News
Submit Video
  • Login
  • Register
  • Home
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Politics
  • Sports
  • Technology
  • Travel
  • Weather
  • World News
  • Videos
  • More
    • Podcasts
    • Reels
    • Live Video Stream
No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Politics
  • Sports
  • Technology
  • Travel
  • Weather
  • World News
  • Videos
  • More
    • Podcasts
    • Reels
    • Live Video Stream
No Result
View All Result
INBV News
No Result
View All Result
Home Health

We’re buying the dip in a health and life sciences stock that has gone down enough

INBV News by INBV News
September 25, 2025
in Health
395 4
0
We’re buying the dip in a health and life sciences stock that has gone down enough
548
SHARES
2.5k
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price comments

Genentech launches direct to consumer program for flu pill Xofluza

We’re buying 20 more shares of Danaher at roughly $180 each. Following Thursday’s trade, Jim Cramer’s Charitable Trust will own 470 shares of DHR, increasing its weighting to about 2.31% from about 2.22%. While Danaher has actually been certainly one of a handful of problematic stocks within the portfolio, we’re moving into the name here, as we expect Thursday’s 3% move lower is overdone. One key investing principle that we have now long held, and that has come back to bite us after we didn’t adhere to it, is that giving up on value is a sin. Danaher does have its share of issues, and the health-care sector usually hasn’t been the best neighborhood to be in, but there comes a degree when those issues are priced in. We predict that time is true here, at around $180. Danaher is exposed to health-care markets through its diagnostics business and to biotech through life sciences. Not only are shares trading at the bottom level in five years — with a transient exception being the times immediately after President Donald Trump ‘s “reciprocal” tariff announcement in early April — they are actually entering oversold territory. Nonetheless, based on current estimates, shares of Danaher are also trading at their most cost-effective valuation since December 2018, on a forward price-to-earnings basis. Because of this, we feel we must hold our nose and buy back a portion of shares we sold at higher prices over the summer. DHR 5Y mountain Danaher 5 years Along with trading at these suppressed levels, we’re stepping in because the corporate earlier this month authorized the repurchase of as much as 35 million shares, or slightly below 5% of shares outstanding. Management is little doubt seeing the identical stock price and valuation dynamics as we’re, and we look forward to finding out that they’re. too, buying here right alongside us. With this purchase, we’re buying back 20 of the 100 shares of Danaher sold in July, and upgrading the stock to our buy-equivalent 1 rating. We’re keeping our price goal at $240 per share. (Jim Cramer’s Charitable Trust is long DHR. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you’ll receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked a few stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.

0

Do you believe most people eat a healthy diet?

Tags: buyingdipHealthLifeSciencesStock
Share219Tweet137
INBV News

INBV News

Related Posts

edit post
Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price comments

Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price comments

by INBV News
October 18, 2025
0

Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration goals to chop the...

edit post
Genentech launches direct to consumer program for flu pill Xofluza

Genentech launches direct to consumer program for flu pill Xofluza

by INBV News
October 17, 2025
0

An indication is posted in front of a Genentech office on June 12, 2025 in South San Francisco, California. Justin...

edit post
Trump pronounces efforts to expand access to IVF drugs

Trump pronounces efforts to expand access to IVF drugs

by INBV News
October 17, 2025
0

US President Donald Trump makes an announcement within the Oval Office of the White House in Washington, DC, on Oct....

edit post
We’re downgrading it, considering next move

We’re downgrading it, considering next move

by INBV News
October 16, 2025
0

Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered one other less-than-stellar quarter. Revenue within...

edit post
DuPont prepares to spinoff electronics. What investors get with the remaining firm

DuPont prepares to spinoff electronics. What investors get with the remaining firm

by INBV News
October 15, 2025
0

Earlier within the week, we checked out the upcoming DuPont electronics business spinoff and what investors are getting with the...

Next Post
edit post
Billy Vigar dead at 21 after suffering brain injury during game

Billy Vigar dead at 21 after suffering brain injury during game

edit post
Judge Anthropic case preliminary OK to $1.5B settlement with authors

Judge Anthropic case preliminary OK to $1.5B settlement with authors

CATEGORIES

  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Podcast
  • Politics
  • Sports
  • Technology
  • Travel
  • Videos
  • Weather
  • World News

CATEGORY

  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Podcast
  • Politics
  • Sports
  • Technology
  • Travel
  • Videos
  • Weather
  • World News

SITE LINKS

  • About us
  • Contact us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • DMCA

[mailpoet_form id=”1″]

  • About us
  • Contact us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • DMCA

© 2022. All Right Reserved By Inbvnews.com

No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Politics
  • Sports
  • Technology
  • Travel
  • Weather
  • World News
  • Videos
  • More
    • Podcasts
    • Reels
    • Live Video Stream

© 2022. All Right Reserved By Inbvnews.com

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist